Abstract
The aim of this study was to examine the body composition in stages 3b to 5 of chronic kidney disease. There were 149 patients included in the study, with the mean age of 65.5 ± 16.5 years, body mass index (BMI) of 29.4 ± 5.6 kg/m2, and estimated glomerular filtration rate (eGFR) of 23.2 ± 9.3/min/1.73m2. They remained with dialysis. Body composition was measured using bioimpedance spectroscopy, and handgrip strength was measured with a hydraulic dynamometer. The main biochemical markers assessed consisted of serum protein, albumin, prealbumin, high-sensitivity C-reactive protein (hsCRP), and interleukin (IL)-6 content. We found that 39% of patients were overweight and 41% were obese. Obesity was more prevalent in stage 3b of chronic kidney disease than in stages 4–5 in women and in patients older than 60 years of age. Thirty-eight percent of the study population were sarcopenic, of whom 20% presented a sarcopenic obesity phenotype. There were significant associations between lean tissue index (LTI) and serum prealbumin content and handgrip strength. Fat tissue index (FTI) was associated and hsCRP, serum protein, body mass index (BMI), waist-hip ratio, and waist-to-height ratio. There were inverse associations between FTI-LTI and LTI-age. We conclude that the prevalence of obesity in non-dialysis-dependent patients with chronic kidney disease is higher than that in the general population. Earlier stages of chronic kidney disease are associated with a higher prevalence of obesity.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anderson LJ, Liu H, Garcia JM (2017) Sex differences in muscle wasting. Adv Exp Med Biol 1043:153–197
Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG (2014) Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 62:253–260
Baria F, Kamimura MA, Aoike DT, Ammirati A, Rocha ML, de Mello MT, Cuppari L (2014) Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrol Dial Transplant 29:857–864
Beleigoli AM, Boersma E, Diniz Mde F, Lima-Costa MF, Ribeiro AL (2012) Overweight and class I obesity are associated with lower 10-year risk of mortality in Brazilian older adults: the Bambuí Cohort Study of Ageing. PLoS One 7(12):e52111
Bosello O, Donataccio MP, Cuzzolaro M (2016) Obesity or obesities? Controversies on the association between body mass index and premature mortality. Eat Weight Disord 21:165–174
Cobo G, Gallar P, Di Gioia C, García Lacalle C, Camacho R, Rodriguez I, Ortega O, Mon C, Vigil A, Lindholm B, Carrero JJ (2017) Hypogonadism associated with muscle atrophy, physical inactivity and ESA hyporesponsiveness in men undergoing haemodialysis. Nefrologia 37(1):54–60
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423
Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel JP, Sieber C, Stout JR, Studenski SA, Vellas B, Woo J, Zamboni M, Cederholm T (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:748–759
Dierkes J, Dahl H, Lervaag Welland N, Sandnes K, Sæle K, Sekse I, Marti HP (2018) High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy – an observational cross-sectional study. BMC Nephrol 19:259
Evangelista LS, Cho WK, Kim Y (2018) Obesity and chronic kidney disease: a population-based study among South Koreans. PLoS One 13(2):e0193559
Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS (2008) Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 52:39–48
Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostics criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398
Gunta SS, Mak RH (2013) Ghrelin and leptin pathophysiology in chronic kidney disease. Pediatr Nephrol 28:611–616
Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Bàràny P, Heimbürger O, Cederholm T, Stenvinkel P, Carrero JJ (2014) Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 9:1720–1728
Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509
Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, Kim HJ, Song YR (2014) Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 33:64–68
Kopple JD, Feroze U (2011) The effect of obesity on chronic kidney disease. J Ren Nutr 21:66–71
Koyun D, Nergizoglu G, Kir KM (2018) Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients. Saudi J Kidney Dis Transpl 29:809–815
Laviano A, Gori C, Rianda S (2014) Sarcopenia and nutrition. Adv Food Nutr Res 71:101–136
Lim HS, Park YH, Suh K, Yoo MH, Park HK, Kim HJ, Lee JH, Byun DW (2018) Association between sarcopenia, sarcopenic obesity, and chronic disease in Korean elderly. J Bone Metab 25:187–193
Matsuo Y, Mitsuyoshi T, Shintani T, Iizuka Y, Mizowaki T (2018) Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer. J Geriatr Oncol 9:589–593
Mihaescu A, Avram C, Bob F, Gaita D, Schiller O, Schiller A (2013) Benefits of exercise training during hemodialysis sessions: a prospective cohort study. Nephron Clin Pract 124:72–78
Moskven E, Bourassa-Moreau É, Charest-Morin R, Flexman A, Street J (2018) The impact of frailty and sarcopenia on postoperative outcomes in adult spine surgery. A systematic review of the literature. Spine J 18(12):2354–2369
Okamura H, Kimura N, Tanno K, Mieno M, Matsumoto H, Yamaguchi A, Adachi H (2018) The impact of preoperative sarcopenia, defined based on psoas muscle area, on long-term outcomes of heart valve surgery. J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2018.06.098
Park JM, Lee JH, Jang HM, Park Y, Kim YS, Kang SW, Yang CW, Kim NH, Kwon E, Kim HJ, Lee JE, Jung HY, Choi JY, Park SH, Kim CD, Cho JH, Kim YL, Clinical Research Center for End Stage Renal Disease (CRC for ESRD) Investigators (2018) Survival in patients on hemodialysis: effect of gender according to body mass index and creatinine. PLoS One 13:e0196550
Pinho EM, Lourenço P, Silva S, Laszczyńska O, Leite AB, Gomes F, Pimenta J, Azevedo A, Bettencourt P (2015) Higher BMI in heart failure patients is associated with longer survival only in the absence of diabetes. J Cardiovasc Med (Hagerstown) 16:576–582
Rosenberger J, Kissova V, Majernikova M, Straussova Z, Boldizsar J (2014) Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality. J Ren Nutr 24:172–176
Rymarz A, Gibińska J, Zajbt M, Piechota W, Niemczyk S (2018) Low lean tissue mass can be a predictor of one-year survival in hemodialysis patients. Ren Fail 40:231–237
Sakuma K, Yamaguchi A (2012) Novel intriguing strategies attenuating to sarcopenia. J Aging Res 2012:251217
Sotillo C, López-Jurado M, Aranda P, López-Frías M, Sánchez C, Llopis J (2007) Body composition in an adult population in southern Spain: influence of lifestyle factors. Int J Vitam Nutr Res 77:406–414
Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J (2017) Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J 10:170–175
WHO – Obesity (2019) http://www.who.int/topics/obesity/en/. Accessed on 31 Aug 2019
Yuki A, Otsuka R, Kozakai R, Kitamura I, Okura T, Ando F, Shimokata H (2013) Relationship between low free testosterone levels and loss of muscle mass. Sci Rep 3:1818
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was accepted by an institutional ethics committee.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rymarz, A., Zajbt, M., Jeznach-Steinhagen, A., Woźniak-Kosek, A., Niemczyk, S. (2019). Body Composition and Biochemical Markers of Nutrition in Non-dialysis-Dependent Chronic Kidney Disease Patients. In: Pokorski, M. (eds) Trends in Biomedical Research. Advances in Experimental Medicine and Biology(), vol 1251. Springer, Cham. https://doi.org/10.1007/5584_2019_444
Download citation
DOI: https://doi.org/10.1007/5584_2019_444
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41218-0
Online ISBN: 978-3-030-41219-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)